investorscraft@gmail.com

Intrinsic ValueAsahi Printing Co.,Ltd. (3951.T)

Previous Close¥894.00
Intrinsic Value
Upside potential
Previous Close
¥894.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Asahi Printing Co., Ltd. operates as a specialized manufacturer of high-quality printing and packaging solutions, primarily serving Japan's pharmaceutical and cosmetic industries. The company's core revenue model revolves around producing OTC medicine packages, prescription drug packaging, cosmetic packaging, and related instructional materials, alongside offering packaging machinery for automation and inspection. Its niche focus on regulated industries ensures steady demand, given stringent compliance requirements for pharmaceutical labeling and packaging. Asahi Printing differentiates itself through precision engineering, customization capabilities, and long-standing client relationships, positioning it as a trusted supplier in a competitive but stable market segment. The company’s secondary revenue stream includes packaging machinery for blister packaging, liquid filling, and corrugated box solutions, enhancing its vertical integration. While domestic-focused, its expertise in high-margin, low-volume packaging for regulated goods provides resilience against broader economic cyclicality.

Revenue Profitability And Efficiency

Asahi Printing reported revenue of JPY 41.87 billion for FY 2024, with net income of JPY 1.63 billion, reflecting a net margin of approximately 3.9%. Operating cash flow stood at JPY 3.55 billion, though capital expenditures of JPY 2.9 billion indicate ongoing investments in production capacity. The company maintains moderate profitability, with diluted EPS of JPY 75.3, supported by its focus on specialized, high-value packaging solutions.

Earnings Power And Capital Efficiency

The company’s earnings power is underpinned by its niche market positioning, with stable demand from pharmaceutical and cosmetic clients. Capital efficiency appears balanced, with capex nearly offsetting operating cash flow, suggesting reinvestment for growth or maintenance. Debt levels of JPY 20.06 billion against cash reserves of JPY 8.94 billion indicate manageable leverage, though interest coverage and ROIC metrics would provide further clarity.

Balance Sheet And Financial Health

Asahi Printing’s balance sheet shows JPY 8.94 billion in cash against total debt of JPY 20.06 billion, implying a net debt position of JPY 11.12 billion. The debt-to-equity ratio is not provided, but the company’s market cap of JPY 18.58 billion suggests moderate leverage. Liquidity appears adequate, with operating cash flow covering interest obligations, though detailed working capital metrics would enhance the assessment.

Growth Trends And Dividend Policy

Growth trends are likely tied to Japan’s pharmaceutical and cosmetic sectors, which exhibit steady but modest expansion. The company paid a dividend of JPY 38 per share, yielding approximately 2% based on current market cap, reflecting a commitment to shareholder returns. Future growth may depend on automation adoption or expansion into adjacent regulated packaging markets.

Valuation And Market Expectations

With a market cap of JPY 18.58 billion and a beta of -0.03, Asahi Printing is perceived as a low-volatility, defensive play. The P/E ratio of approximately 11.4x (based on diluted EPS) aligns with niche industrial peers. Investors likely value its stable cash flows and dividend yield, though limited international exposure may cap premium potential.

Strategic Advantages And Outlook

Asahi Printing’s strategic advantages include deep regulatory expertise, long-term client relationships, and vertical integration in packaging machinery. The outlook remains stable, supported by Japan’s aging population driving pharmaceutical demand. Risks include reliance on domestic markets and potential margin pressure from raw material costs. Diversification into healthcare-adjacent packaging or automation services could unlock incremental growth.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount